Back to Trades
Cahill Thomas
DirectorCIK 0001922939
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Cahill Thomas, Director, has filed 2 SEC reports (2025–2026), all concentrated in Prime Medicine, Inc. (PRME), totaling $1.5M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jun 8 | PRME Prime Medicine, Inc. | Cahill Thomas | Director | Award | $229.5K |
| Aug 5 | PRME Prime Medicine, Inc. | Cahill Thomas | Director | Award | $1.3M |
2 filings